These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19748059)

  • 1. Insulin secretion in healthy subjects and patients with Type 2 diabetes--role of the gastrointestinal tract.
    Ma J; Rayner CK; Jones KL; Horowitz M
    Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):413-24. PubMed ID: 19748059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
    O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL
    Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gastrointestinal tract and glucose tolerance.
    Vella A; Camilleri M; Rizza RA
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):479-84. PubMed ID: 15192453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut: A Key to the Pathogenesis of Type 2 Diabetes?
    Holst JJ; Pedersen J; Wewer Albrechtsen NJ; Knop FK
    Metab Syndr Relat Disord; 2017 Aug; 15(6):259-262. PubMed ID: 28605280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
    Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
    Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.
    Salehi M; Aulinger B; Prigeon RL; D'Alessio DA
    Diabetes; 2010 Jun; 59(6):1330-7. PubMed ID: 20215429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.
    Maggs D; MacDonald I; Nauck MA
    Diabetes Obes Metab; 2008 Jan; 10(1):18-33. PubMed ID: 17490426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
    Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric emptying in diabetes: an overview.
    Horowitz M; Wishart JM; Jones KL; Hebbard GS
    Diabet Med; 1996 Sep; 13(9 Suppl 5):S16-22. PubMed ID: 8894465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.
    Smits MM; Tonneijck L; Muskiet MH; Kramer MH; Cahen DL; van Raalte DH
    Diabetes Obes Metab; 2016 Mar; 18(3):224-35. PubMed ID: 26500045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes.
    Gentilcore D; Chaikomin R; Jones KL; Russo A; Feinle-Bisset C; Wishart JM; Rayner CK; Horowitz M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2062-7. PubMed ID: 16537685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
    Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
    Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood glucose and insulin secretion after meals rich in simple and complex carbohydrates, in non-insulin-dependent diabetics].
    Bosquet F; Grimaldi A; Grenet C; Hervet F
    Presse Med; 1985 Nov; 14(38):1955-8. PubMed ID: 2933707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duodenal glucose load impacts the oral disposition index in healthy subjects.
    Marathe CS; Feinle-Bisset C; Pilichiewicz A; Lange K; Jones KL; Rayner CK; Kahn SE; Horowitz M
    Diabet Med; 2015 Nov; 32(11):1500-3. PubMed ID: 25981372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nutrition and health--carbohydrates, the risks to health from the postprandial glycaemic response and the possibilities for its manipulation].
    Wachters-Hagedoorn RE; Priebe MG; Vonk RJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(33):1626-30. PubMed ID: 15455509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for the dietary management of diabetes mellitus.
    Welch IM; Bruce C; Hill SE; Read NW
    Clin Sci (Lond); 1987 Feb; 72(2):209-16. PubMed ID: 3545642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.
    Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):550-9. PubMed ID: 19036624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.
    Vella A; Bock G; Giesler PD; Burton DB; Serra DB; Saylan ML; Dunning BE; Foley JE; Rizza RA; Camilleri M
    Diabetes; 2007 May; 56(5):1475-80. PubMed ID: 17303799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.